RD
RDZNW
Roadzen Inc.
$0.1200
0.00%
$18.3M
No data for this timeframe.
Vol
Market Cap$18.3M
Cap SizeNano Cap
SEC Reports5
Exchange Nasdaq·Sector Insurance Agents, Brokers & Service·Inc. D8·CIK 0001868640·Prev Close $0.1200
Recent Activity
Jun 5, 2026
SEC
Roadzen Inc. and its institutional investor agreed to a Third Amendment deferring installment payments due on two junior
8-K — Impact 5/10
May 7, 2026
SEC
Roadzen Inc. disclosed via an 8-K that it is a beta testing partner for Anthropic's Managed Agents Platform (MAP) and is
8-K — Impact 3/10
May 5, 2026
SEC
Roadzen Inc. is conducting a best-efforts equity offering of 4,705,870 ordinary shares at $1.70 per share, targeting gro
424B5 — Impact 7/10
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 2 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 5.6/10.
BEARISH
8-K
5/10
Roadzen Inc. and its institutional investor agreed to a Third Amendment deferring installment paymen
Jun 5, 2026
NEUTRAL
8-K
3/10
Roadzen Inc. disclosed via an 8-K that it is a beta testing partner for Anthropic's Managed Agents P
May 7, 2026
BEARISH
424B5
7/10
Roadzen Inc. is conducting a best-efforts equity offering of 4,705,870 ordinary shares at $1.70 per
May 5, 2026
BULLISH
8-K
6/10
Roadzen's VehicleCare subsidiary won a contract from one of India's largest general insurers to proc
Apr 28, 2026
BULLISH
8-K
7/10
Roadzen Inc. disclosed during an investor conference that it is operating at an annualized revenue r
Apr 10, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 34.1% | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 47.7% | — |
| Current FY 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 22.3% | — |
| Next FY 2027-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 62.4% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.